Pangenomic Health Inc.
NARA
CNSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 21.70K | 10.20K | 20.80K | 9.50K | 9.30K |
Total Receivables | 23.20K | 32.10K | 32.40K | 32.00K | 77.50K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | 2.20K | 4.70K | 28.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 44.90K | 42.20K | 55.40K | 46.20K | 114.80K |
|
|||||
Total Current Assets | 44.90K | 42.20K | 55.40K | 46.20K | 114.80K |
Net Property, Plant & Equipment | 1.60K | 3.10K | 5.50K | 8.00K | 10.10K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 46.50K | 45.30K | 60.80K | 54.10K | 124.90K |
|
|||||
Total Accounts Payable | 630.80K | 617.70K | 553.80K | 604.90K | 630.20K |
Total Accrued Expenses | -- | 351.10K | -- | -- | 86.40K |
Short-term Debt | -- | -- | 712.50K | 730.50K | 463.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 633.20K | 157.20K | 511.20K | 342.60K | 296.80K |
Total Other Current Liabilities | 633.20K | 157.20K | 511.20K | 342.60K | 296.80K |
Total Current Liabilities | 1.26M | 1.13M | 1.78M | 1.68M | 1.48M |
|
|||||
Total Current Liabilities | 1.26M | 1.13M | 1.78M | 1.68M | 1.48M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | 712.50K | 730.50K | 463.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.26M | 1.13M | 1.78M | 1.68M | 1.48M |
|
|||||
Common Stock & APIC | 10.52M | 10.39M | 8.91M | 9.14M | 8.78M |
Retained Earnings | -15.48M | -15.14M | -13.42M | -13.60M | -12.86M |
Treasury Stock & Other | 3.73M | 3.67M | 2.79M | 2.83M | 2.73M |
Total Common Equity | -1.22M | -1.08M | -1.72M | -1.62M | -1.35M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.22M | -1.08M | -1.72M | -1.62M | -1.35M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.22M | -1.08M | -1.72M | -1.62M | -1.35M |
|